Skip to main content

Table 1 SHR and WKY plasma testosterone and plasma norepinephrine levels by treatment groupa

From: Alterations in vasomotor systems and mechanics of resistance-sized mesenteric arteries from SHR and WKY male rats following in vivo testosterone manipulation

Treatment

Strain

CONT

CAST

CAST + T

Testosterone (ng/ml)

SHR

1.88 ± 0.52

0.05 ± 0.60

12.9 ± 0.70

 

WKY

1.08 ± 0.52

0.04 ± 0.70

11.0 ± 0.78

Norepinephrine (pg/ml)

SHR

970.5 ± 88.4***

481.5 ± 50.4**

762.2 ± 53.8*

 

WKY

569.5 ± 28.1

415.5 ± 97.3

644.9 ± 74.6

  1. aCAST, castrate; CAST + T, castrate plus testosterone; CONT, control; NE, norepinephrine; SHR: spontaneously hypertensive rat; T: testosterone; WKY: Wistar Kyoto. Data are means ± SEM. Plasma T was unaltered between SHR and WKY T-manipulated groups. Plasma NE was significantly higher in SHR CONT males than in WKY CONT males (***P < 0.001). Plasma NE was decreased in SHR CAST compared to CONT (**P < 0.01) and increased compared to CAST + T (*P < 0.05).